Vector production in academia: obstacles and opportunitiesPublished: May 5, 2020
Viral vector bioprocessing & analytics: today’s key tools and innovation requirements to meet future demand
DANIELA BISCHOF is an Assistant Professor of Clinical Medical and Molecular Genetics, and Director of Vector Production at the Indiana University School of Medicine. She has almost 20 years of experience in the field of gene therapy and has been involved in the production of clinical grade gene therapy lentiviral and retroviral products since 2007.
EMILY HOPEWELL is the Director of Cell and Gene Therapy Manufacturing and an Assistant Professor in Clinical Medical and Molecular Genetics at Indiana University, and is charged with implementing and building manufacturing for cell, gene, and immune therapy at Indiana University.
Citation: Cell & Gene Therapy Insights 2020; 6(3), 267- 273